US Stock MarketDetailed Quotes

SLNO Soleno Therapeutics

Watchlist
  • 41.1700
  • -1.7000-3.97%
Close May 23 16:00 ET
  • 41.1700
  • 0.00000.00%
Post 16:01 ET
1.52BMarket Cap-19888P/E (TTM)

Soleno Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-86.21%-12.53M
-20.01%-24.94M
-22.77%-6.31M
-36.00%-6.33M
-20.48%-5.57M
-5.75%-6.73M
25.17%-20.78M
25.06%-5.14M
13.87%-4.66M
42.34%-4.62M
Net income from continuing operations
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
22.14%-24.07M
-93.99%-5.49M
24.67%-6.13M
38.80%-6.73M
Operating gains losses
----
706.67%182K
-47,100.00%-470K
32,750.00%653K
----
----
94.09%-30K
100.72%1K
98.21%-2K
96.43%-2K
Depreciation and amortization
0.00%490K
-0.31%1.96M
0.20%489K
-0.41%490K
-0.61%489K
-0.41%490K
0.05%1.96M
-0.81%488K
0.00%492K
0.41%492K
Other non cash items
19.34%469K
819.19%3.04M
318.86%1.15M
432.84%1.09M
-40.99%406K
149.81%393K
4.74%-422K
83.90%-525K
-67.10%204K
-77.87%688K
Change In working capital
1,600.88%1.94M
487.30%2.93M
852.96%1.91M
-1.01%98K
127.81%811K
111.90%114K
34.15%-756K
83.62%-253K
-88.04%99K
124.98%356K
-Change in prepaid assets
124.25%81K
-840.71%-837K
-194.64%-660K
3,666.67%113K
-80.00%44K
-392.98%-334K
181.29%113K
50.88%-224K
-98.72%3K
1,566.67%220K
-Change in payables and accrued expense
195.19%3.87M
192.12%1.54M
225.83%190K
-38.35%-570K
467.07%613K
238.62%1.31M
-177.32%-1.68M
80.57%-151K
-319.15%-412K
89.20%-167K
-Change in other current liabilities
-208.70%-100K
640.43%762K
372.32%738K
40.51%222K
-835.48%-290K
2,966.67%92K
-10.16%-141K
0.00%-271K
-36.55%158K
52.31%-31K
-Change in other working capital
-100.10%-1.91M
54.17%1.46M
316.54%1.64M
-4.86%333K
32.93%444K
-633.85%-954K
441.88%947K
585.19%393K
122.93%350K
38.59%334K
Cash from discontinued investing activities
Operating cash flow
-86.21%-12.53M
-20.01%-24.94M
-22.77%-6.31M
-36.00%-6.33M
-20.48%-5.57M
-5.75%-6.73M
25.17%-20.78M
25.06%-5.14M
13.87%-4.66M
42.34%-4.62M
Investing cash flow
Cash flow from continuing investing activities
-115.24M
0
0
0
0
0
40.91%-13K
53.85%-6K
0
Net PPE purchase and sale
---11K
--0
--0
--0
--0
--0
40.91%-13K
53.85%-6K
--0
----
Net investment purchase and sale
---115.23M
----
----
----
----
--0
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
---115.24M
--0
--0
--0
--0
--0
40.91%-13K
53.85%-6K
--0
---7K
Financing cash flow
Cash flow from continuing financing activities
938K
1,177.46%180.02M
123.56M
11,420.76%39.4M
6,149.65%17.06M
0
11,109.38%14.09M
0
342K
-14,200.00%-282K
Net common stock issuance
----
877.15%137.86M
--117.93M
739.77%2.87M
----
----
--14.11M
--0
--342K
---282K
Proceeds from stock option exercised by employees
--938K
--42.16M
--5.63M
----
----
--0
--0
--0
----
----
Net other financing activities
----
----
----
----
----
----
86.67%-16K
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
--938K
1,177.46%180.02M
--123.56M
11,420.76%39.4M
6,149.65%17.06M
--0
11,109.38%14.09M
--0
--342K
-14,200.00%-282K
Net cash flow
Beginning cash position
1,062.04%169.68M
-31.46%14.6M
165.49%52.44M
-19.52%19.37M
-72.82%7.87M
-31.46%14.6M
-56.72%21.3M
-29.92%19.75M
-28.37%24.07M
-30.36%28.97M
Current changes in cash
-1,785.17%-126.83M
2,413.92%155.08M
2,377.02%117.24M
866.55%33.07M
334.14%11.49M
-187.72%-6.73M
76.00%-6.7M
25.17%-5.15M
20.27%-4.31M
38.72%-4.91M
End cash Position
444.16%42.85M
1,062.04%169.68M
1,062.04%169.68M
165.49%52.44M
-19.52%19.37M
-72.82%7.87M
-31.46%14.6M
-31.46%14.6M
-29.92%19.75M
-28.37%24.07M
Free cash flow
-86.37%-12.54M
-19.94%-24.94M
-22.63%-6.31M
-36.00%-6.33M
-20.29%-5.57M
-5.75%-6.73M
25.18%-20.79M
25.12%-5.15M
13.95%-4.66M
42.26%-4.63M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -86.21%-12.53M-20.01%-24.94M-22.77%-6.31M-36.00%-6.33M-20.48%-5.57M-5.75%-6.73M25.17%-20.78M25.06%-5.14M13.87%-4.66M42.34%-4.62M
Net income from continuing operations -156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M22.14%-24.07M-93.99%-5.49M24.67%-6.13M38.80%-6.73M
Operating gains losses ----706.67%182K-47,100.00%-470K32,750.00%653K--------94.09%-30K100.72%1K98.21%-2K96.43%-2K
Depreciation and amortization 0.00%490K-0.31%1.96M0.20%489K-0.41%490K-0.61%489K-0.41%490K0.05%1.96M-0.81%488K0.00%492K0.41%492K
Other non cash items 19.34%469K819.19%3.04M318.86%1.15M432.84%1.09M-40.99%406K149.81%393K4.74%-422K83.90%-525K-67.10%204K-77.87%688K
Change In working capital 1,600.88%1.94M487.30%2.93M852.96%1.91M-1.01%98K127.81%811K111.90%114K34.15%-756K83.62%-253K-88.04%99K124.98%356K
-Change in prepaid assets 124.25%81K-840.71%-837K-194.64%-660K3,666.67%113K-80.00%44K-392.98%-334K181.29%113K50.88%-224K-98.72%3K1,566.67%220K
-Change in payables and accrued expense 195.19%3.87M192.12%1.54M225.83%190K-38.35%-570K467.07%613K238.62%1.31M-177.32%-1.68M80.57%-151K-319.15%-412K89.20%-167K
-Change in other current liabilities -208.70%-100K640.43%762K372.32%738K40.51%222K-835.48%-290K2,966.67%92K-10.16%-141K0.00%-271K-36.55%158K52.31%-31K
-Change in other working capital -100.10%-1.91M54.17%1.46M316.54%1.64M-4.86%333K32.93%444K-633.85%-954K441.88%947K585.19%393K122.93%350K38.59%334K
Cash from discontinued investing activities
Operating cash flow -86.21%-12.53M-20.01%-24.94M-22.77%-6.31M-36.00%-6.33M-20.48%-5.57M-5.75%-6.73M25.17%-20.78M25.06%-5.14M13.87%-4.66M42.34%-4.62M
Investing cash flow
Cash flow from continuing investing activities -115.24M0000040.91%-13K53.85%-6K0
Net PPE purchase and sale ---11K--0--0--0--0--040.91%-13K53.85%-6K--0----
Net investment purchase and sale ---115.23M------------------0----------------
Cash from discontinued investing activities
Investing cash flow ---115.24M--0--0--0--0--040.91%-13K53.85%-6K--0---7K
Financing cash flow
Cash flow from continuing financing activities 938K1,177.46%180.02M123.56M11,420.76%39.4M6,149.65%17.06M011,109.38%14.09M0342K-14,200.00%-282K
Net common stock issuance ----877.15%137.86M--117.93M739.77%2.87M----------14.11M--0--342K---282K
Proceeds from stock option exercised by employees --938K--42.16M--5.63M----------0--0--0--------
Net other financing activities ------------------------86.67%-16K--0--0--0
Cash from discontinued financing activities
Financing cash flow --938K1,177.46%180.02M--123.56M11,420.76%39.4M6,149.65%17.06M--011,109.38%14.09M--0--342K-14,200.00%-282K
Net cash flow
Beginning cash position 1,062.04%169.68M-31.46%14.6M165.49%52.44M-19.52%19.37M-72.82%7.87M-31.46%14.6M-56.72%21.3M-29.92%19.75M-28.37%24.07M-30.36%28.97M
Current changes in cash -1,785.17%-126.83M2,413.92%155.08M2,377.02%117.24M866.55%33.07M334.14%11.49M-187.72%-6.73M76.00%-6.7M25.17%-5.15M20.27%-4.31M38.72%-4.91M
End cash Position 444.16%42.85M1,062.04%169.68M1,062.04%169.68M165.49%52.44M-19.52%19.37M-72.82%7.87M-31.46%14.6M-31.46%14.6M-29.92%19.75M-28.37%24.07M
Free cash flow -86.37%-12.54M-19.94%-24.94M-22.63%-6.31M-36.00%-6.33M-20.29%-5.57M-5.75%-6.73M25.18%-20.79M25.12%-5.15M13.95%-4.66M42.26%-4.63M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg